Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07791745 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Trial Comparing the Efficacy and Safety of Anyouping® and Platinum-based Chemotherapy With or Without Enlituo® in Advanced Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Name: A Clinical Trial Comparing the Efficacy and Safety of Anyouping® and Platinum-based Chemotherapy With or Without Enlituo® in Advanced Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. — clinical trial record (NCT07791745)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 2/3

SponsorTaizhou Mabtech Pharmaceutical Co.,Ltd

Started2026-08-30

View on ClinicalTrials.gov ↗

A Clinical Trial Comparing the Efficacy and Safety of Anyouping® and Platinum-based Chemotherapy With Enlituo® in Advanced Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Trial Details

NCT Number	NCT07791745
Lead Sponsor	Taizhou Mabtech Pharmaceutical Co.,Ltd
Conditions	Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Enrollment	362 participants
Start Date	2026-08-30
Primary Completion	2032-08-30 (estimated)
Study Completion	2032-08-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-28